Breast Cancer Clinical Trial

MRI Parenchymal Enhancement: A New Marker of Breast Cancer Risk

Summary

The purpose of this study is to learn about how a woman's health history influences what a normal breast looks like on an MRI. The investigators also want to learn about how the amount of different natural hormones a woman has affects how the breast looks on an MRI. The investigator's hope is that this will help to find women at a high-risk of breast cancer.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

age 21 years or older
be a cancer-free pre- or postmenopausal woman
have no prior personal history of any cancer (including DCIS, excluding nonmelanoma skin-cancer)
able to speak and read English because the questionnaire is only available in English
able to provide informed consent

Exclusion Criteria:

are pregnant at the time of MRI
have a prior personal history of any cancer (including DCIS, excluding nonmelanoma skin cancer)

Study is for people with:

Breast Cancer

Estimated Enrollment:

437

Study ID:

NCT01649661

Recruitment Status:

Completed

Sponsor:

Memorial Sloan Kettering Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Memorial Sloan Kettering Cancer Center
New York New York, 10021, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

437

Study ID:

NCT01649661

Recruitment Status:

Completed

Sponsor:


Memorial Sloan Kettering Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider